** Shares of Actinogen Medical Ltd fall as much as 14.3% to A$0.030, their lowest since Aug 26
** The biotechnology firm raises A$11.1 mln ($7.51 mln) via share placement and share purchase plan
** The placement price of A$0.03 per share represents a 14.3% discount to ACW's last closing price
** Co says funds from capital raise will be used to accelerate enrolment and trial of patients with Alzheimer's disease
** ACW stock up 36.4% YTD
($1 = 1.4789 Australian dollars)
(Reporting by Ayushman Ojha in Bengaluru)
((Ayushman.ojha@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments